Analysis of Circulating Tumor DNA for Early Relapse Detection in Stage III Colorectal Cancer ESMO 2020
Circulating tumor DNA (ctDNA) has emerged as a promising biomarker for early prediction of relapse across different tumor types.
Circulating tumor DNA (ctDNA) has emerged as a promising biomarker for early prediction of relapse across different tumor types.